{"id":"NCT02662569","sponsor":"Amgen","briefTitle":"Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia","officialTitle":"A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia (BERSON)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-04-14","primaryCompletion":"2017-12-06","completion":"2017-12-06","firstPosted":"2016-01-25","resultsPosted":"2019-01-11","lastUpdate":"2019-01-11"},"enrollment":986,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes, Hyperlipidemia, Mixed Dyslipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Atorvastatin","otherNames":["Lipitor"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Atorvastatin (Q2W)","type":"ACTIVE_COMPARATOR"},{"label":"Atorvastatin (QM)","type":"ACTIVE_COMPARATOR"},{"label":"Evolocumab Q2W + Atorvastatin","type":"EXPERIMENTAL"},{"label":"Evolocumab QM + Atorvastatin","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145) in combination with statin therapy (atorvastatin) on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in diabetic adults with hyperlipidemia or mixed dyslipidemia.","primaryOutcome":{"measure":"Percent Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","timeFrame":"Baseline and weeks 10 and 12","effectByArm":[{"arm":"Placebo Q2W","deltaMin":4.94,"sd":3.48},{"arm":"Placebo QM","deltaMin":0.99,"sd":3.31},{"arm":"Evolocumab Q2W","deltaMin":-65.35,"sd":3.09},{"arm":"Evolocumab QM","deltaMin":-69.05,"sd":2.96}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":110,"countries":["United States","Argentina","Brazil","Canada","China","Colombia","France","Russia","South Korea","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["32318641","30851062"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":164},"commonTop":["Diabetes mellitus","Upper respiratory tract infection","Nasopharyngitis","Hypertension","Cough"]}}